Showing results (121-130 of 180) with videos related to
Sort By:
Pageof 18
Molecular and Cellular Biochemistry|May 20, 1999
Role of brefeldin A-dependent ADP-ribosylation in the control of intracellular membrane transportM G Silletta, A Colanzi, R Weigert, et al.Nature Cell Biology|January 10, 2002
The GM130 and GRASP65 Golgi proteins cycle through and define a subdomain of the intermediate compartmentP Marra, T Maffucci, T Daniele, et al.Clinical and Experimental Immunology|October 15, 2015
NET amyloidogenic backbone in human activated neutrophilsL Pulze, B Bassani, E Gini, et al.British Journal of Cancer|October 23, 2008
Preoperative bevacizumab combined with letrozole and chemotherapy in locally advanced ER- and/or PgR-positive breast cancer: clinical and biological activityR Torrisi, V Bagnardi, A Cardillo, et al.Nuclear Medicine Communications|October 21, 1999
Radiation protection in radioguided surgery of breast cancerM Cremonesi, M Ferrari, E Sacco, et al.The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 13, 2002
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspectsC De Cicco, M Pizzamiglio, G Trifirò, et al.Advances in Experimental Medicine and Biology|January 1, 1997
Characterization of the endogenous mono-ADP-ribosylation stimulated by brefeldin AR Weigert, A Colanzi, C Limina, et al.Cell|January 6, 1999
Procollagen traverses the Golgi stack without leaving the lumen of cisternae: evidence for cisternal maturationL Bonfanti, A A Mironov, J A Martínez-Menárguez, et al.The Journal of Biological Chemistry|June 11, 1999
Molecular cloning and functional characterization of brefeldin A-ADP-ribosylated substrate. A novel protein involved in the maintenance of the Golgi structureS Spanò, M G Silletta, A Colanzi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2015
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situG Curigliano, D Disalvatore, A Esposito, et al.Pageof 18